Bain and Cinven offer improved price to de-list Stada
Bain Capital and Cinven Partners have made an offer of €81.83 per share to the remaining shareholders in listed German drug maker Stada, with plans to de-list the business.
The PE firms said they have obtained irrevocable support for the new offer from an unidentified seller with a 12% stake.
Bain and Cinven jointly acquired a majority stake in the business in August last year at €66.25 per share after having their first bid rejected by shareholders.
Activist investor Elliott Management currently holds a 15.24% stake in Stada, according to Unquote sister publication Mergermarket. In September 2017, Bain and Cinven announced that they had agreed to purchase Elliott Management's Stada shares for €74.4 per share to secure the hedge fund's support of the takeover bid.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









